We are studying if an investigational RSV vaccine could activate a mother’s immune system to create protective
defenses (antibodies) against RSV that would be passed on to their developing babies.

What is RSV?
RSV or respiratory syncytial virus,  is a very common disease of the airways. For most people, RSV is often mild and causes wheezing, coughing, sneezing, and runny nose. However, for some babies, RSV can be serious, and lead to trouble eating or breathing. This is especially true for infants who are premature or have heart or lung problems.
We are looking for expecting mothers and their babies to take part in this study.

You might qualify if you:
• Are between 18 and 49 years old
• Are healthy and expecting a single healthy baby
• Are in your late second or early third trimester when you receive the study vaccine
• Are not planning on having your baby at home
• Are willing and able to attend health checks and follow instructions from your study team

For more information about this study, please call or send a message and we will answer your questions   OR   visit MatisseRSVstudy.com
Are vaccines safe while pregnant?

In most countries, maternal vaccinations are a regular part of prenatal care, and pregnant mothers are often vaccinated for diseases like the flu, pertussis (whooping cough), and tetanus.
When an expecting mother is vaccinated, she passes on the defenses (antibodies) she builds from the vaccine to her developing baby. This is called a “maternal vaccination.”

Maternal vaccinations are an important way to protect babies in the first few months of life.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.